WallStreetZenWallStreetZen

NASDAQ: FLNA
Filana Therapeutics Inc Stock Ownership - Who owns Filana Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Filana Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Robert Eugene Anderson Jr.Director2025-11-248,600$2.90
$24.94kBuy
Richard BarryPresident CEO2025-11-20150,000$2.76
$414.00kBuy
Richard BarryPresident CEO2025-11-1973,385$2.75
$201.81kBuy
Robert Christopher CookChief Operating Legal Office2025-09-3013,725$2.91
$39.94kBuy
Richard BarryPresident CEO2025-09-227,172$2.28
$16.35kBuy
Richard BarryPresident CEO2025-09-1946,908$2.29
$107.42kBuy
Richard BarryPresident CEO2025-09-19400$2.25
$900.00Buy
Richard BarryPresident CEO2025-09-18185,233$2.24
$414.92kBuy
Richard BarryPresident CEO2025-09-185,400$2.13
$11.50kBuy

1 of 1

FLNA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FLNA insiders and whales buy or sell their stock.

FLNA Shareholders

What type of owners hold Filana Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eastbourne Capital Management LLC29.25%14,131,378$29.53MInsider
Remi Barbier18.27%8,827,362$18.45MInsider
Sabretooth Master Fund LP8.82%4,263,076$8.91MInsider
Black Bear Offshore Master Fund LP8.67%4,186,238$8.75MInsider
Vanguard Group Inc4.92%2,375,589$4.96MInstitution
Marshall Wace LLP4.38%2,115,307$4.42MInstitution
Armistice Capital LLC3.42%1,651,340$3.45MInsider
Blackrock Inc2.94%1,419,934$2.97MInstitution
Sanford Robertson2.35%1,135,851$2.37MInsider
Two Sigma Advisers LP1.98%954,800$2.00MInstitution

1 of 3

FLNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FLNA0.52%73.68%Net Buying
BMEA32.86%25.76%Net Buying
FBIO18.92%48.94%Net Buying
PYXS48.41%37.50%
ANIX16.98%81.46%Net BuyingNet Buying
View Top Biotech Stocks

Filana Therapeutics Stock Ownership FAQ

Who owns Filana Therapeutics?

Filana Therapeutics (NASDAQ: FLNA) is owned by 0.52% institutional shareholders, 73.68% Filana Therapeutics insiders, and 25.80% retail investors. Eastbourne Capital Management LLC is the largest individual Filana Therapeutics shareholder, owning 14.13M shares representing 29.25% of the company. Eastbourne Capital Management LLC's Filana Therapeutics shares are currently valued at $28.12M.

If you're new to stock investing, here's how to buy Filana Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.